1. Introduction

The legal right to reverse genetic enhancements refers to a proposed right of an individual to undo, modify, deactivate, or mitigate the effects of genetic interventions previously undertaken to enhance human characteristics or biological capabilities.

Genetic enhancement may involve editing DNA to influence muscle strength, disease resistance, metabolism, sensory abilities, cognitive functions, or other biological traits. Unlike ordinary medical treatments, some genetic interventions—particularly those affecting cells throughout the body or reproductive cells—may be difficult or impossible to reverse completely.

The central legal question is:

If a person consents to genetic enhancement, should that person also have the right to withdraw consent and demand reversal, even when reversal is medically risky, scientifically impossible, or affects other people?

As of November 2026, there is no widely recognized, standalone legal right specifically guaranteeing the reversal of genetic enhancements. However, related rights and doctrines provide a foundation for legal claims, including bodily autonomy, informed consent, medical negligence, privacy, consumer protection, and human rights.

This discussion focuses primarily on Indian law, with comparative authorities from the United States, the United Kingdom, and international law.

2. Meaning and scope

The proposed right can be divided into five legal dimensions.

Prime Editing in Humans: First Proof | Vastkind

A. Reversal of somatic genetic enhancement

A person seeks to undo genetic changes made to their own non-reproductive cells. The legal issue is whether the provider must offer a safe reversal or another remedy if the person changes their mind.

CRISPR: Implications for materials science

B. Reversal of unintended effects

A person seeks correction of harmful side effects, off-target mutations, or other unintended consequences. Negligence, product liability, and statutory remedies may become relevant.

ZagrebMed - Decoding Your DNA: The Rise of Personalized Medicine

C. Reversal after withdrawal of consent

A person no longer wants an enhancement, even if it was initially lawful and properly performed. This raises questions about continuing consent, personal autonomy, and the limits of a provider's obligations.

Genome editing reveals role of gene important for human embryo development

D. Heritable genetic modifications

An intervention affects reproductive cells or embryos and may be transmitted to descendants. Reversal becomes more complex because future individuals may be affected and the original intervention may not be confined to one person's body.

Best Targeted Therapy for Cancer in India - Advanced Treatment

E. Access to corrective treatment

Even where literal genetic reversal is impossible, a person may seek treatment for the consequences, long-term monitoring, compensation, or access to alternative therapies.

A crucial distinction is that the right to refuse further treatment is not the same as a right to demand a scientifically impossible reversal. The law may protect autonomy and provide remedies without being able to restore the person's original biological condition.

3. Legal foundations in India

A. Article 21: Right to life, dignity, and bodily autonomy

Article 21 of the Constitution of India protects life and personal liberty. Judicial interpretation has extended this protection to bodily integrity, decisional autonomy, dignity, and important aspects of personal privacy.

In a genetic-enhancement dispute, Article 21 may support arguments that:

A competent adult should be able to refuse additional genetic interventions.

Medical providers must respect informed decisions about treatment.

A person harmed by an unauthorized or negligently performed procedure should have access to appropriate legal remedies.

Genetic information and decisions about one's body deserve protection against unjustified interference.

However, Article 21 does not automatically establish an enforceable right to have a genetic alteration reversed. A court would need to examine the nature of the intervention, the available scientific evidence, applicable laws, and the remedy sought.

B. Informed consent and medical law

Consent to genetic enhancement should be distinguished from consent to future corrective treatment. A person who agreed to an original intervention has not necessarily agreed to every subsequent procedure required to maintain or reverse it.

Relevant questions include whether the provider disclosed:

The possibility that the intervention could be irreversible.

Known and reasonably foreseeable long-term risks.

The limits of available reversal methods.

Alternative treatments and monitoring requirements.

The financial and medical consequences of complications.

In India, the Supreme Court's decision in Samira Kohli v. Dr. Prabha Manchanda, (2008) 2 SCC 1, is an important authority on the scope and validity of medical consent. It supports the principle that consent to one procedure does not ordinarily authorize a materially different procedure without appropriate consent, subject to recognized exceptions.

C. Statutory and regulatory framework

India's genetic-therapy framework includes the National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019, issued through the work of the Indian Council of Medical Research (ICMR), the Central Drugs Standard Control Organisation (CDSCO), and the Department of Biotechnology (DBT). These guidelines address the safety and ethical oversight of gene-therapy products and clinical trials.

2019+1

Other potentially relevant legal frameworks include:

Drugs and Cosmetics Act, 1940, and New Drugs and Clinical Trials Rules, 2019: Regulatory requirements applicable to gene-therapy products and relevant clinical trials.

Environment (Protection) Act, 1986, and applicable biosafety rules: Oversight relevant to genetically engineered organisms or cells, depending on the activity.

Consumer Protection Act, 2019: Potential remedies where a qualifying service deficiency or other statutory ground is established.

Contract and tort principles: Possible remedies for breach of contractual obligations, negligent treatment, inadequate disclosure, or foreseeable injury.

These frameworks regulate aspects of research, treatment, safety, and liability. They do not, merely by regulating gene therapy, create a universal entitlement to reverse a completed genetic modification.

4. Important case laws and their relevance

The following decisions provide legal principles that may be applied by analogy. None of the cases listed below directly establishes a general right to reverse genetic enhancement.

Case 1: Samira Kohli v. Dr. Prabha Manchanda

Supreme Court of India · (2008) 2 SCC 1

Legal principle: Medical consent must be valid and sufficiently informed; authorization for one procedure does not ordinarily extend to a substantially different procedure without further consent.

Relevance to genetic reversal: A clinic cannot assume that consent to genetic enhancement automatically includes consent to later interventions, repeat editing, or experimental corrective procedures. Conversely, a patient who requests reversal must still obtain appropriate medical assessment and provide consent for the proposed corrective procedure.

Likely legal application: Where the original intervention exceeded the consent given, or material risks were not properly disclosed, the case may support a claim concerning unauthorized treatment or deficient consent.

Case 2: Justice K.S. Puttaswamy (Retd.) v. Union of India

Supreme Court of India · (2017) 10 SCC 1

Legal principle: Privacy is a fundamental right under the Constitution, closely connected with dignity, liberty, and individual autonomy.

Relevance to genetic reversal: Decisions about genetic characteristics, access to genetic information, and the use of sensitive biological data may engage constitutional privacy interests. A person may argue that genetic decisions should remain under meaningful individual control, subject to lawful restrictions.

Limitation: The judgment does not recognize a specific right to undo DNA modifications or compel a medical provider to perform a reversal.

Case 3: Jacob Puliyel v. Union of India

Supreme Court of India · (2022) 7 SCC 1

Legal principle: The Court examined bodily integrity and decisional autonomy in the context of vaccination policy, including the limits on compelling medical interventions.

Relevance to genetic reversal: Its reasoning may support an argument that bodily autonomy includes a significant interest in refusing further medical intervention. A person should not automatically be compelled to undergo additional editing merely because they previously consented to enhancement.

Limitation: Refusing a future intervention is legally distinct from demanding that a completed intervention be undone. The judgment does not decide the latter question.

Case 4: Common Cause v. Union of India

Supreme Court of India · (2018) 5 SCC 1

Legal principle: The Court recognized important dimensions of personal autonomy, dignity, and decision-making concerning medical treatment at the end of life.

Relevance to genetic reversal: The decision may contribute to broader arguments that competent individuals have a substantial interest in making personal medical decisions and refusing certain interventions.

Limitation: The case concerns end-of-life decisions and advance medical directives. It does not authorize genetic reversal or establish a general right to obtain any requested medical procedure.

Case 5: Montgomery v. Lanarkshire Health Board

Supreme Court of the United Kingdom · [2015] UKSC 11

Legal principle: Doctors generally must take reasonable care to ensure that patients are aware of material risks and reasonable alternatives to proposed treatment.

Relevance to genetic reversal: If a genetic-enhancement provider fails to disclose that a modification may be permanent, or omits material information about available alternatives, the reasoning may help assess whether consent was adequate.

Limitation: This is a UK decision, not binding Indian precedent. Its persuasive value depends on the issue and the applicable Indian law.

Case 6: He Jiankui human gene-editing case

China · Criminal conviction reported in 2019

In 2018, scientist He Jiankui announced the birth of children whose embryos had been gene-edited. In 2019, Chinese authorities reported that he had been convicted of illegal medical practice and sentenced to three years' imprisonment. The experiment generated serious concerns about informed consent, research ethics, safety, and heritable genetic modifications.

Stanford Law School+1

Relevance to genetic reversal: The case illustrates the legal consequences that can follow unauthorized or unethical genetic experimentation. It also demonstrates why future children cannot simply be treated as parties whose parents' consent resolves every ethical and legal question.

Limitation: The prosecution did not establish a general right for genetically edited children to have their genomes restored to their original state.

5. International legal principles

Several international instruments are relevant to the development of legal protections for individuals who seek to reverse genetic enhancements.

The UNESCO Declaration emphasizes dignity and the protection of individuals irrespective of their genetic characteristics. Article 5 addresses rigorous prior assessment of risks and benefits and consent for interventions affecting an individual's genome. The Oviedo Convention, where applicable, restricts genome-modifying interventions to preventive, diagnostic, or therapeutic purposes and prohibits interventions intended to introduce modifications into descendants.

OUP Academic+1

These principles help frame the debate but do not independently establish a universal, directly enforceable right to genetic reversal.

6. Can a person legally demand reversal?

The answer depends on the circumstances.

Scenario A: The person withdraws consent

A competent adult generally has strong grounds to refuse further treatment. Whether the person can demand reversal depends on medical feasibility, applicable law, and the provider's obligations.

Scenario B: The procedure caused negligent harm

A claim for damages, corrective treatment costs, or other relief may be available if negligence, causation, and legally recognized injury are established. Reversal itself is not guaranteed.

Scenario C: The clinic concealed irreversibility

Material non-disclosure may support a claim based on deficient informed consent, negligence, or consumer law, depending on the facts. The appropriate remedy may be compensation rather than genetic restoration.

Scenario D: Reversal is scientifically impossible

A court generally cannot make an unavailable biological technique possible by issuing an order. Alternative relief may include monitoring, treatment of complications, compensation, or access to scientifically supported care.

7. Major legal challenges

A. Scientific feasibility

Genetic modifications may involve many cells, multiple genes, or changes that become integrated into cellular DNA. A treatment capable of editing a particular genetic sequence does not necessarily offer a safe way to restore every affected cell.

The US Food and Drug Administration's 2024 guidance on human gene-therapy products incorporating genome editing emphasizes product design, testing, nonclinical safety assessment, and clinical-trial design. This regulatory approach illustrates why reversal cannot be assumed to be safe merely because an original modification was technically possible.

FDA

B. The right to refuse versus the right to receive treatment

The law traditionally distinguishes between:

Negative autonomy: refusing an intervention or withdrawing from treatment where legally permitted.

Positive entitlement: requiring another person, institution, or public authority to provide a particular treatment.

The second claim generally requires an additional legal basis. Patient autonomy does not automatically entitle an individual to a procedure that is scientifically unvalidated or outside reasonable medical practice. This distinction is also reflected in the Indian Supreme Court's January 2026 decision in Yash Charitable Trust v. Union of India, concerning the limits of patient choice in medical procedures.

Indian Kanoon

C. Genetic modifications affecting descendants

Germline modifications create difficult questions because genetic changes may be transmitted to future generations. The person requesting reversal may not be the only person affected, and no individual can give informed consent on behalf of all future descendants.

This makes reproductive and heritable genetic interventions legally distinct from modifications confined to an adult's somatic cells. International scholarship identifies unresolved questions about the legality, ethical justification, and intergenerational consequences of heritable human genome editing.

OUP Academic+1

D. Allocation of costs

If reversal is medically indicated, the question arises as to who should pay. Depending on the facts, responsibility might fall on the individual, the treating institution, a manufacturer, an insurer, or a public healthcare system.

A provider's financial responsibility is more plausible where the need for corrective treatment results from negligence, breach of contract, inadequate disclosure, or a legally actionable product defect. A mere change of preference does not necessarily make the original provider liable for the cost of reversal.

8. Proposed legal framework for a right to genetic reversal

A carefully designed legal framework could recognize a limited right to seek reversal without promising an impossible outcome.

The following safeguards would be useful:

Pre-intervention disclosure: Providers must explain reversibility, irreversibility, uncertainties, and likely long-term costs.

Continuing autonomy: Adults must be able to refuse additional enhancement or maintenance procedures, subject to lawful exceptions.

Assessment of reversal requests: An independent specialist should assess the safety, feasibility, and proportionality of proposed corrective treatment.

Remedies for wrongful harm: The law should clarify when providers must fund corrective treatment, monitoring, rehabilitation, or compensation.

Protection against coercion: Employers, insurers, and other institutions should not unlawfully pressure people into genetic enhancement or reversal.

Special safeguards for children: Decisions involving minors should prioritize their welfare, developing autonomy, and ability to participate in decisions as they mature.

Long-term monitoring and privacy: Appropriate follow-up should be available while protecting genetic information and respecting legally valid decisions about continued participation in research.

India's existing gene-therapy guidelines provide a regulatory starting point for safety, clinical oversight, and informed consent. A distinct statutory or regulatory framework would be needed to specify any new entitlement to reversal and its limits.

2019+1

9. Conclusion

The legal right to reverse genetic enhancements is an emerging legal concept at the intersection of constitutional law, medical law, bioethics, biotechnology regulation, and human rights.

In India, Article 21, the right to privacy, informed-consent principles, medical negligence law, and applicable statutory protections provide possible foundations for claims involving genetic enhancement. The decisions in Samira Kohli, K.S. Puttaswamy, and Jacob Puliyel are particularly relevant to consent, autonomy, and bodily integrity.

Nevertheless, the right to refuse further genetic intervention is legally distinct from a right to compel the restoration of one's original genome. A claim for reversal must account for scientific feasibility, medical safety, the rights of other affected persons, and the applicable legal framework.

The strongest future approach would recognize a right to request an independent assessment and appropriate corrective care, together with effective remedies where wrongful conduct has caused harm—without guaranteeing a biological outcome that medicine cannot safely deliver.

Legal note: This is a comparative legal overview, not an assertion that a standalone right to reverse genetic enhancement currently exists in Indian law. Any real claim would require analysis of the specific intervention, consent documents, clinical evidence, and applicable regulations.